Session » (0252–0282) Miscellaneous Rheumatic & Inflammatory Diseases Poster I
-
Abstract Number: 0252
Characterizing Granulomatous Mastitis: A Retrospective, Single-Institutional Case Series of a Racially and Ethnically Diverse Cohort
-
Abstract Number: 0253
Clinical Phenotypes in Patients with Isolated Anti-Sm/RNP Common Motif Antibody Positivity, Compared to Those with or Without Associated Anti-RNP Antibody Reactivity
-
Abstract Number: 0254
Microvascular and Cutaneous Assessment in Adult Patients with Hypermobile Ehlers-Danlos Syndrome
-
Abstract Number: 0255
Lymphoid Mass in the Inferior Turbinate with IgG4 Producing Cells: A Nasal Manifestation of IgG4-RD or a Distinct Chronic Inflammatory Disease?
-
Abstract Number: 0256
Nintedanib in Combination with Immunosuppressive Agents Improves Forced Vital Capacity in Connective Tissue Disease-associated PF-ILD: A Single-center Study
-
Abstract Number: 0257
Activity of IgG4-related Disease Differs Depending on the Presence or Absence of Concomitant Hypocomplementemia
-
Abstract Number: 0258
Understanding Monogenic Behçet’s Disease Pathophysiology: Impact of Pathogenic Variant L227X Associated with Autoinflammatory A20 Haploinsufficiency on Cellular Survival and Proliferation
-
Abstract Number: 0259
Preliminary Experience with a Novel “Fix” for Deep Epitope and Transcriptional Phenotyping of Fragile Cells from Autoinflammatory Flares
-
Abstract Number: 0260
Phenotypes of the Patients with More Than One Autoinflammatory Gene Variant: Classified Diseases and Mixed Autoinflammatory Disorders (MAID)
-
Abstract Number: 0261
Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results
-
Abstract Number: 0262
Destructive Arthritis in Whipple Disease. a Single-center Case Series of 14 Patients
-
Abstract Number: 0263
Patient, Disease, and Treatment Factors in Remission of Inflammatory Eye Disease
-
Abstract Number: 0264
A Novel Role for Rheumatologists: Managing Idiopathic Granulomatous Mastitis
-
Abstract Number: 0265
Differential and Combinatorial Mechanism of Action of Golimumab and Guselkumab in Ulcerative Colitis Induction Therapy: IL-23 Blockade Drives Restoration of Normal Epithelium and Mucosal Healing
-
Abstract Number: 0266
E-selectin, ICAM-1 and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases
-
Abstract Number: 0267
Variations in Approach to the Diagnosis and Management of Polymyalgia Rheumatica Among Australian Rheumatologists
-
Abstract Number: 0268
Safety and Efficacy of CT-guided Percutaneous Infra-Renal Periaortic Biopsies in Suspected Retroperitoneal Fibrosis
-
Abstract Number: 0269
Acute Kidney Injury and Plasma Cell-Rich Acute Interstitial Nephritis in VEXAS Syndrome: An Under-recognized Disease Feature
-
Abstract Number: 0271
Successful Treatment of Refractory IgG4-Related Disease with Tofacitinib: Experiences from 7 Patients
-
Abstract Number: 0272
Risk Factors for Severe Outcome in Susac Syndrome: A National Cohort Study
-
Abstract Number: 0273
Disease Characteristics and Pancreatic Damage in IgG4-Related Disease with Pancreatic Involvement
-
Abstract Number: 0274
A Mix-and-match COVID-19 Vaccination Strategy in Patients with Rheumatic Diseases on Rituximab
-
Abstract Number: 0275
No Cumulative Effect of Infection Rates in Children Receiving Long-term Canakinumab Treatment in Autoinflammatory Periodic Fever Syndromes − Data from the RELIANCE Registry
-
Abstract Number: 0276
Disease Control in Patients with Monogenetic Autoinflammatory Diseases Under Canakinumab Treatment – Comparison of 30 Months Interim Data from the RELIANCE Registry
-
Abstract Number: 0277
Anti-carbamylated Antibodies in Autoimmunity – Focus on Their Diagnostic and Prognostic Value: A Systematic Review and Meta-analysis
-
Abstract Number: 0278
NOD2 Genotyping Landscape in Yao Syndrome
-
Abstract Number: 0279
Therapeutic Exploration of Immune Checkpoint Inhibitor Induced Inflammatory Arthritis In Vivo
-
Abstract Number: 0280
Immunosuppression in the Treatment of Susac Syndrome: A Retrospective Evaluation of the Largest Cohort of Susac Syndrome